The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein

Hiromitsu Jinno, Masakazu Ueda, Soji Ozawa, Tadashi Ikeda, Masaki Kitajima, Takashi Maeda, Niasaharu Seno

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Conventional targeted therapy with foreign proteins is highly immunogenic. In this study, we developed targeted therapy composed of human endogenous proteins and evaluated its efficacy in vitro. Materials and Methods: Human epidermal growth factor (EGF) was chemically linked to human eosinophil cationic protein (ECP). The cytotoxicity of the EGF-ECP conjugate was evaluated by MTT assay. Results: The conjugate showed dose-dependent cytotoxicity on EGF receptor (EGFR) -overexpressing BT-20 cells with an IC50 of 1.5 × 10-7 M, whereas the IC50 of ECP alone was almost 10 M. The conjugate had no detectable cytotoxicity against EGF receptor-deficient H69 cells. Excess EGF protected BT-20 cells from the cytotoxicity of the conjugate. Comparing the cytotoxicity and the level of EGFR expression, the cytotoxicity of the conjugate was positively correlated with the level of EGFR expression of each cell line. Conclusion: Conjugates composed solely of human proteins might be useful with less immunogenicity and less toxicity than the conventional immunotoxins for targeted therapy.

Original languageEnglish
Pages (from-to)4141-4145
Number of pages5
JournalAnticancer Research
Volume22
Issue number6 C
Publication statusPublished - 2002 Nov

Fingerprint

Eosinophil Cationic Protein
Epidermal Growth Factor Receptor
Epidermal Growth Factor
Inhibitory Concentration 50
Immunotoxins
Proteins
Therapeutics
Cell Line

Keywords

  • Breast cancer
  • Conjugate
  • Eosinophil cationic protein
  • Epidermal growth factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Jinno, H., Ueda, M., Ozawa, S., Ikeda, T., Kitajima, M., Maeda, T., & Seno, N. (2002). The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein. Anticancer Research, 22(6 C), 4141-4145.

The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein. / Jinno, Hiromitsu; Ueda, Masakazu; Ozawa, Soji; Ikeda, Tadashi; Kitajima, Masaki; Maeda, Takashi; Seno, Niasaharu.

In: Anticancer Research, Vol. 22, No. 6 C, 11.2002, p. 4141-4145.

Research output: Contribution to journalArticle

Jinno, H, Ueda, M, Ozawa, S, Ikeda, T, Kitajima, M, Maeda, T & Seno, N 2002, 'The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein', Anticancer Research, vol. 22, no. 6 C, pp. 4141-4145.
Jinno H, Ueda M, Ozawa S, Ikeda T, Kitajima M, Maeda T et al. The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein. Anticancer Research. 2002 Nov;22(6 C):4141-4145.
Jinno, Hiromitsu ; Ueda, Masakazu ; Ozawa, Soji ; Ikeda, Tadashi ; Kitajima, Masaki ; Maeda, Takashi ; Seno, Niasaharu. / The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein. In: Anticancer Research. 2002 ; Vol. 22, No. 6 C. pp. 4141-4145.
@article{697063519d8f434fa35db1cb641416ec,
title = "The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein",
abstract = "Background: Conventional targeted therapy with foreign proteins is highly immunogenic. In this study, we developed targeted therapy composed of human endogenous proteins and evaluated its efficacy in vitro. Materials and Methods: Human epidermal growth factor (EGF) was chemically linked to human eosinophil cationic protein (ECP). The cytotoxicity of the EGF-ECP conjugate was evaluated by MTT assay. Results: The conjugate showed dose-dependent cytotoxicity on EGF receptor (EGFR) -overexpressing BT-20 cells with an IC50 of 1.5 × 10-7 M, whereas the IC50 of ECP alone was almost 10 M. The conjugate had no detectable cytotoxicity against EGF receptor-deficient H69 cells. Excess EGF protected BT-20 cells from the cytotoxicity of the conjugate. Comparing the cytotoxicity and the level of EGFR expression, the cytotoxicity of the conjugate was positively correlated with the level of EGFR expression of each cell line. Conclusion: Conjugates composed solely of human proteins might be useful with less immunogenicity and less toxicity than the conventional immunotoxins for targeted therapy.",
keywords = "Breast cancer, Conjugate, Eosinophil cationic protein, Epidermal growth factor",
author = "Hiromitsu Jinno and Masakazu Ueda and Soji Ozawa and Tadashi Ikeda and Masaki Kitajima and Takashi Maeda and Niasaharu Seno",
year = "2002",
month = "11",
language = "English",
volume = "22",
pages = "4141--4145",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6 C",

}

TY - JOUR

T1 - The cytotoxicity of a conjugate composed of human epidermal growth factor and eosinophil cationic protein

AU - Jinno, Hiromitsu

AU - Ueda, Masakazu

AU - Ozawa, Soji

AU - Ikeda, Tadashi

AU - Kitajima, Masaki

AU - Maeda, Takashi

AU - Seno, Niasaharu

PY - 2002/11

Y1 - 2002/11

N2 - Background: Conventional targeted therapy with foreign proteins is highly immunogenic. In this study, we developed targeted therapy composed of human endogenous proteins and evaluated its efficacy in vitro. Materials and Methods: Human epidermal growth factor (EGF) was chemically linked to human eosinophil cationic protein (ECP). The cytotoxicity of the EGF-ECP conjugate was evaluated by MTT assay. Results: The conjugate showed dose-dependent cytotoxicity on EGF receptor (EGFR) -overexpressing BT-20 cells with an IC50 of 1.5 × 10-7 M, whereas the IC50 of ECP alone was almost 10 M. The conjugate had no detectable cytotoxicity against EGF receptor-deficient H69 cells. Excess EGF protected BT-20 cells from the cytotoxicity of the conjugate. Comparing the cytotoxicity and the level of EGFR expression, the cytotoxicity of the conjugate was positively correlated with the level of EGFR expression of each cell line. Conclusion: Conjugates composed solely of human proteins might be useful with less immunogenicity and less toxicity than the conventional immunotoxins for targeted therapy.

AB - Background: Conventional targeted therapy with foreign proteins is highly immunogenic. In this study, we developed targeted therapy composed of human endogenous proteins and evaluated its efficacy in vitro. Materials and Methods: Human epidermal growth factor (EGF) was chemically linked to human eosinophil cationic protein (ECP). The cytotoxicity of the EGF-ECP conjugate was evaluated by MTT assay. Results: The conjugate showed dose-dependent cytotoxicity on EGF receptor (EGFR) -overexpressing BT-20 cells with an IC50 of 1.5 × 10-7 M, whereas the IC50 of ECP alone was almost 10 M. The conjugate had no detectable cytotoxicity against EGF receptor-deficient H69 cells. Excess EGF protected BT-20 cells from the cytotoxicity of the conjugate. Comparing the cytotoxicity and the level of EGFR expression, the cytotoxicity of the conjugate was positively correlated with the level of EGFR expression of each cell line. Conclusion: Conjugates composed solely of human proteins might be useful with less immunogenicity and less toxicity than the conventional immunotoxins for targeted therapy.

KW - Breast cancer

KW - Conjugate

KW - Eosinophil cationic protein

KW - Epidermal growth factor

UR - http://www.scopus.com/inward/record.url?scp=0036875373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036875373&partnerID=8YFLogxK

M3 - Article

C2 - 12553045

AN - SCOPUS:0036875373

VL - 22

SP - 4141

EP - 4145

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6 C

ER -